Is there any rule for antiviral therapy in HBV-related compensated cirrhosis patients with serum HBV DNA undetectable or at low levels and normal ALT?

被引:0
|
作者
Yan, Taotao [1 ]
Sha, Xiaoying [3 ]
Wang, Jing [1 ]
Jin, Li [1 ]
Zhang, Yu [2 ]
Yi, Ruitian [1 ]
Cao, Furong [1 ]
Yang, Yuan [2 ]
Liu, Jinfeng [2 ]
He, Yingli [2 ]
Chen, Tianyan [2 ]
Zhao, Yingren [2 ]
机构
[1] Xi An Jiao Tong Univ, Xian 710049, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian 710049, Peoples R China
[3] Eighth Hosp Xian, Dept Infect Dis, Xian, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1541
引用
收藏
页码:961A / 962A
页数:3
相关论文
共 50 条
  • [31] Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy
    Battistella, Sara
    Lynch, Erica N.
    Gambato, Martina
    Zanetto, Alberto
    Pellone, Monica
    Shalaby, Sara
    Sciarrone, Salvatore
    Ferrarese, Alberto
    Germani, Giacomo
    Senzolo, Marco
    Burra, Patrizia
    Russo, Francesco P.
    MINERVA GASTROENTEROLOGY, 2021, 67 (01): : 38 - 49
  • [32] Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
    Jong-In Chang
    Dong Hyun Sinn
    Hyun Cho
    Seonwoo Kim
    Wonseok Kang
    Geum-Youn Gwak
    Yong-Han Paik
    Moon Seok Choi
    Joon Hyeok Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Digestive Diseases and Sciences, 2022, 67 : 4565 - 4573
  • [33] Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis
    Ikeda, K
    Arase, Y
    Kobayashi, M
    Someya, T
    Saitoh, S
    Suzuki, Y
    Suzuki, F
    Tsubota, A
    Akuta, N
    Kumada, H
    INTERVIROLOGY, 2003, 46 (02) : 96 - 104
  • [34] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
    Ramakrishna, H. K.
    INDIAN JOURNAL OF SURGERY, 2022, 84 (05) : 1136 - 1137
  • [35] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
    Ramakrishna HK
    Indian Journal of Surgery, 2022, 84 : 1136 - 1137
  • [36] Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL
    Lee, Hankil
    Jang, Sungin
    Ahn, Sang Hoon
    Kim, Beom Kyung
    HEPATOLOGY INTERNATIONAL, 2022, 16 (02) : 294 - 305
  • [37] Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis
    Lin, Dong
    Ding, Jing
    Liu, Jian-Ying
    He, Yi-Feng
    Dai, Zhi
    Chen, Cai-Zhong
    Cheng, Wei-Zhong
    Zhou, Jian
    Wang, Xin
    PLOS ONE, 2013, 8 (06):
  • [38] Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
    Huang, Yan
    Chen, Lichang
    Huang, Rui
    Zhu, Chuanwu
    Shang, Jia
    Qian, Yunsong
    Lian, Jianqi
    Liu, Longgen
    Jiang, Jianning
    Liu, Chenghai
    Gui, Honglian
    Xie, Qing
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [39] Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
    Lenci, Ilaria
    Tisone, Giuseppe
    Di Paolo, Daniele
    Marcuccilli, Fabio
    Tariciotti, Laura
    Ciotti, Marco
    Svicher, Valentina
    Perno, Carlo Federico
    Angelico, Mario
    JOURNAL OF HEPATOLOGY, 2011, 55 (03) : 587 - 593
  • [40] Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
    Chang, Jong-In
    Sinn, Dong Hyun
    Cho, Hyun
    Kim, Seonwoo
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (09) : 4565 - 4573